is zepbound a glp-1 agonist Dose-equivalence reference based on pivotal GLP-1/dual-agonist trials: SURMOUNT-1 (tirzepatide/Zepbound, 72 weeks) STEP-1 (subcutaneous semaglutide/Wegovy, 68 weeks) OASIS-4 (oral semaglutide/Wegovy, 64 weeks). For educational comparison only—these are Zepbound to Wegovy GLP-1/GIP Ratio

Facilitates Growth and Development Studies have found that higher concentrations of IGF-1 in fetuses result in lager fetal size

RAxML version 8: a tool for phylogenetic analysis and post-analysis of large phylogenies

(A ) PLS-DA score plot as multivariate data analyses based on metabolomics data between three tamoxifen-treated groups (each group contains 9 samples) compared to the control group (n = 9)

Shen F, Gaffen SL

ABSTRACT: Objective: This systematic review aims to critically assess the literature on the mechanisms of action, clinical uses, formulation strategies, and adverse effects of self-tanning agents, with a focus on dihydroxyacetone (DHA), melanotan, forskolin, and carotenoids

Other lesions that may be safely left alone are physiologic melanin deposits (usually gingival and buccal) in dark-skinned persons and oral pigmentation associated with pregnancy, Peutz-Jeghers syndrome, Recklinghausens disease, HIV infection, and Laugier-Hunziker syndrome